Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome [Phase 1, Phase 2]

View source ↗

Summary

An early-phase clinical trial evaluating CXCR4-targeted PET/CT imaging for diagnosing Cushing's syndrome (both ACTH-dependent and ACTH-independent).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cushing s Syndrome | Phase 1, Phase 2 | Status: RECRUITING